Article Data

  • Views 1493
  • Dowloads 146

Case Report

Open Access

Excessive anticoagulation identified by emergency medical service through point-of-care coagulometry

  • CHRISTOPHER BEYNON1
  • ANGELINA G ERK1,2
  • STEFAN MOHR2
  • FELIX HEISER2
  • ERIK POPP2

1Department of Neurosurgery, Heidelberg University Hospital

2Department of Anaesthesiology, Heidelberg University Hospital

DOI: 10.22514/SV101.042015.9 Vol.10,Issue 1,April 2015 pp.121-126

Published: 30 April 2015

*Corresponding Author(s): CHRISTOPHER BEYNON E-mail: christopher.beynon@med.uni-heidelberg.de

Abstract

Bleeding because of excessive anticoagulation is a well-recognized complication of coumadin therapy. In cases of potentially life-threatening bleeding such as intracranial haemorrhage, reversal of anticoagulation should be carried out as soon as possible. Here we report the case of an emergency patient in whom excessive anticoagulation was diagnosed at the scene by emergency medical service personnel through the use of a point-of-care coagulometer. Following hospital admission, findings were confirmed by central laboratory assessment of prothrombin time. The time gained through the use of portable coagulometers may contribute to improved pre-hospital emergency management of anticoagulated patients.

Keywords

anticoagulation, bedside testing, warfarin, haemorrhage

Cite and Share

CHRISTOPHER BEYNON,ANGELINA G ERK,STEFAN MOHR,FELIX HEISER,ERIK POPP. Excessive anticoagulation identified by emergency medical service through point-of-care coagulometry. Signa Vitae. 2015. 10(1);121-126.

References

1. Karni A, Holtzman R, Bass T, Zorman G, Carter L, Rodriguez, et al. Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg

2001;67:1098–100.

2. Bereznicki LR, Jackson SL, Peterson GM, Jeffrey EC, Marsden KA, Jupe DM. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007;60:311–4. doi:10.1136/jcp.2006.037820

3. Verret L, Couturier J, Rozon A, Saudrais-Janecek S, St-Onge A, Nguyen A, et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy 2012;32:871–9. doi:10.1002/j.1875-9114.2012.01116

4. Beynon C, Jakobs M, Rizos T, Unterberg AW, Sakowitz OW. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients. Br J Neurosurg 2014;28:29–33. doi:10.3109/02688697.2013.869549

5. Lendrum RA, Kotze J-P, Lockey DJ, Weaver AE. Case studies in prehospital care from London HEMS: pre-hospital administration of prothrombin complex concentrate to the head-injured patient. Emerg Med J 2013;30:247–8.

doi:10.1136/emermed-2012-202302

6. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013;17:R76. doi:10.1186/cc12685

7. Van den Brule JMD, Romkes JH, Brouwer MA, Noyez L. An error in the CoaguChek S device results in prosthetic heart valve thrombosis. Interact Cardiovasc Thorac Surg 2010;11:123–4. doi:10.1510/icvts.2010.233288

8. Cotte J, D’Aanda E, Chauvin V, Kaiser E, Meaudre E. Point-of-Care Coagulation Testing for Trauma Patients in a Military Setting: A Prospective Study. J Spec Oper Med 2013;13:59–62.

9. Mitra B, O’Reilly G, Collecutt M, Cameron PA, Phillips L, Davis A. Prospective comparison of point-of-care international normalised ratio measurement versus plasma international normalised ratio for acute traumatic coagulopathy. Emerg Med Australas 2012;24:363–8. doi:10.1111/j.1742-6723.2012.01556.x

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top